| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.35B | 12.39B | 11.46B | 12.64B | 12.04B | 9.89B |
| Gross Profit | 2.96B | 2.93B | 2.56B | 3.05B | 3.01B | 2.20B |
| EBITDA | 1.38B | 1.33B | 1.06B | 1.46B | 1.51B | 1.07B |
| Net Income | 670.00M | 676.00M | 527.00M | 767.00M | 870.00M | -62.00M |
Balance Sheet | ||||||
| Total Assets | 17.76B | 17.63B | 17.14B | 16.81B | 16.45B | 14.99B |
| Cash, Cash Equivalents and Short-Term Investments | 3.59B | 3.31B | 3.50B | 4.53B | 3.93B | 2.48B |
| Total Debt | 2.48B | 2.48B | 2.50B | 2.52B | 2.48B | 2.50B |
| Total Liabilities | 5.20B | 5.07B | 5.02B | 5.55B | 5.71B | 4.98B |
| Stockholders Equity | 12.56B | 12.56B | 12.11B | 11.25B | 10.74B | 10.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 95.00M | -830.00M | 951.00M | 1.60B | 718.00M |
| Operating Cash Flow | 0.00 | 1.02B | 289.00M | 1.17B | 1.91B | 1.34B |
| Investing Cash Flow | 0.00 | -942.00M | -1.07B | -238.00M | -252.00M | -513.00M |
| Financing Cash Flow | 0.00 | -261.00M | -302.00M | -341.00M | -246.00M | -552.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥10.74B | 7.66 | ― | 3.48% | 0.24% | 20.23% | |
73 Outperform | ¥8.73B | 5.48 | ― | 2.92% | 5.71% | 169.04% | |
69 Neutral | ¥6.52B | -102.51 | ― | 1.06% | 6.41% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥15.39B | 4.33 | ― | 2.87% | 2.38% | -5.80% | |
54 Neutral | ¥21.00B | 3.53 | ― | 4.33% | 5.12% | ― | |
45 Neutral | ¥7.96B | -73.23 | ― | ― | -19.32% | -171.53% |